
Pharma sector had outperformed Nifty by 12 percent in 2020 (since start of pandemic), on account of being a direct beneficiary of the Covid and also as investors rushed towards safety during this uncertain period.
from Moneycontrol Market Outlook https://www.moneycontrol.com/news/market-outlook/daily-voice-|-this-fund-manager-says-earnings-growth-will-be-20-aided-by-strong-toplineq2_16647211.html
No comments:
Post a Comment